---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-044809"
form_type: "8-K"
ticker: "DRIO"
cik: "0001533998"
company_name: "DarioHealth Corp."
filed_at: "2025-05-06T23:59:59+00:00"
generated_at: "2026-05-22T11:41:52.624870+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# DarioHealth enters $32.5M credit agreement with Callodine; warrants issued

## Summary
- Borrowed $32.5M at closing; may draw up to $17.5M more subject to revenue thresholds and lender discretion.
- Loan bears interest at Term SOFR + 7.75%, matures April 2030; secured by substantially all assets.
- Issued warrants to purchase 2,114,140 shares at $0.8278; up to $2.5M loan principal convertible at $0.9933 per share.
- Prior Loan and Security Agreement with Avenue terminated; proceeds used to satisfy LSA.
- Financial covenants include minimum unencumbered liquid assets, total revenue, and Adjusted EBITDA.

## SEC filing metadata
- accession: 0001104659-25-044809
- form_type: 8-K
- ticker: DRIO
- cik: 0001533998
- company_name: DarioHealth Corp.
- filed_at: 2025-05-06T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533998/000110465925044809/0001104659-25-044809-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533998/000110465925044809/tm2514078d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-044809
- JSON: https://secwatch.observer/filing/0001104659-25-044809.json
- Plain text: https://secwatch.observer/filing/0001104659-25-044809.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.